Dipeptidyl-peptidase-4 inhibitors have anti-inflammatory effects in patients with type 2 diabetes

被引：0
|
作者：
Dengpiao Xie
Qiqi Wang
Wei Huang
Liangbin Zhao
机构：
[1] Hospital of Chengdu University of Traditional Chinese Medicine,
来源：
European Journal of Clinical Pharmacology | 2023年 / 79卷
关键词：
Dipeptidyl-peptidase-4 inhibitors; Inflammation; Type 2 diabetes mellitus; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1291 / 1301
页数：10
相关论文
共 50 条
  • [21] PROTECTIVE EFFECTS OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS ON PROGRESSION OF DIABETIC RETINOPATHY IN PATIENTS WITH TYPE 2 DIABETES
    Chung, Yoo-Ri
    Park, Sung Wook
    Kim, Jong Wan
    Kim, Jeong Hun
    Lee, Kihwang
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2016, 36 (12): : 2357 - 2363
  • [22] Renoprotective Effect of Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus
    Esaki, Hiroki
    Tachi, Tomoya
    Goto, Chitoshi
    Sugita, Ikuto
    Kanematsu, Yuta
    Yoshida, Aki
    Saito, Kosuke
    Noguchi, Yoshihiro
    Ohno, Yuki
    Aoyama, Satoshi
    Yasuda, Masahiro
    Mizui, Takashi
    Yamamura, Masumi
    Teramachi, Hitomi
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [23] Educating patients with type 2 diabetes on new class of drug, dipeptidyl peptidase 4 inhibitors
    Siminerio, Linda
    DIABETES EDUCATOR, 2007, 33 : 111S - 113S
  • [24] Dipeptidyl Peptidase 4 Inhibitors and the Risk of Bullous Pemphigoid Among Patients With Type 2 Diabetes
    Douros, Antonios
    Rouette, Julie
    Yin, Hui
    Yu, Oriana Hoi Yun
    Filion, Kristian B.
    Azoulay, Laurent
    DIABETES CARE, 2019, 42 (08) : 1496 - 1503
  • [25] The role of dipeptidyl peptidase 4 inhibitors in fat metabolism in patients with type 2 diabetes and obesity
    Ametov, A. S.
    Gusenbekova, D. G.
    DIABETES MELLITUS, 2015, 18 (03): : 85 - 92
  • [26] Exposure to dipeptidyl-peptidase-4 inhibitors andCOVID-19 among people with type 2 diabetes: A case-control study
    Fadini, Gian Paolo
    Morieri, Mario Luca
    Longato, Enrico
    Bonora, Benedetta Maria
    Pinelli, Silvia
    Selmin, Elisa
    Voltan, Giacomo
    Falaguasta, Daniele
    Tresso, Silvia
    Costantini, Giorgia
    Sparacino, Giovanni
    Di Camillo, Barbara
    Tramontan, Lara
    Cattelan, Anna Maria
    Vianello, Andrea
    Fioretto, Paola
    Vettor, Roberto
    Avogaro, Angelo
    DIABETES OBESITY & METABOLISM, 2020, 22 (10): : 1946 - 1950
  • [27] The Role of Dipeptidyl Peptidase-4 Inhibitors in Fat Metabolism in Patients with Type 2 Diabetes
    Ametov, Alexander S.
    DIABETES, 2017, 66 : A627 - A627
  • [28] Dipeptidyl-peptidase-4 Inhibitors in Type 2 Diabetes and COVID-19: From a Potential Repurposed Agent to a Useful Treatment Option
    Singh, Awadhesh Kumar
    Singh, Ritu
    JOURNAL OF DIABETOLOGY, 2020, 11 (03) : 131 - 136
  • [29] Cost Effectiveness of Dipeptidyl Peptidase-4 Inhibitors for Type 2 Diabetes
    Jinsong Geng
    Hao Yu
    Yiwei Mao
    Peng Zhang
    Yingyao Chen
    PharmacoEconomics, 2015, 33 : 581 - 597
  • [30] Dipeptidyl peptidase-4 inhibitors: their role in the management of type 2 diabetes
    Mkele, Gail
    JOURNAL OF ENDOCRINOLOGY METABOLISM AND DIABETES OF SOUTH AFRICA, 2015, 20 (01) : 64 - 66
12345